No CrossRef data available.
Article contents
Effect of vitamin D supplementation or fortification on bone turnover markers in women: a systematic review and meta-analysis
Published online by Cambridge University Press: 15 January 2024
Abstract
Vitamin D is a vital indicator of musculoskeletal health, as it plays an important role through the regulation of bone and mineral metabolism. This meta-analysis was performed to investigate the effects of vitamin D supplementation/fortification on bone turnover markers in women. All human randomised clinical trials reported changes in bone resorption markers (serum C-terminal telopeptide of type-I collagen (sCTX) and urinary type I collagen cross-linked N-telopeptide (uNTX)) or bone formation factors (osteocalcin (OC), bone alkaline phosphatase (BALP) and procollagen type-1 intact N-terminal propeptide (P1NP)) following vitamin D administration in women (aged ≥ 18 years) were considered. Mean differences (MD) and their respective 95 % CI were calculated based on fixed or random effects models according to the heterogeneity status. Subgroup analyses, meta-regression models, sensitivity analysis, risk of bias, publication bias and the quality of the included studies were also evaluated. We found that vitamin D supplementation had considerable effect on sCTX (MD: −0·038, n 22) and OC (MD: −0·610, n 24) with high heterogeneity and uNTX (MD: −8·188, n 6) without heterogeneity. Our results showed that age, sample size, dose, duration, baseline vitamin D level, study region and quality of studies might be sources of heterogeneity in this meta-analysis. Subgroup analysis also revealed significant reductions in P1NP level in dose less than 600 μg/d and larger study sample size (>100 participants). Moreover, no significant change was found in BALP level. Vitamin D supplementation/fortification significantly reduced bone resorption markers in women. However, results were inconsistent for bone formation markers.
Keywords
- Type
- Systematic Review and Meta-Analysis
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society
References
Sassi, F, Tamone, C & D’Amelio, P (2018) Vitamin D: nutrient, hormone, and immunomodulator. Nutrients 10, 1656.CrossRefGoogle ScholarPubMed
Cashman, KD (2020) Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcified Tissue Int 106, 14–29.CrossRefGoogle ScholarPubMed
Fischer, V, Haffner-Luntzer, M, Amling, M, et al. (2018) Calcium and vitamin D in bone fracture healing and post-traumatic bone turnover. Eur Cell Mater 35, 365–385.CrossRefGoogle ScholarPubMed
Pludowski, P, Takacs, I, Boyanov, M, et al. (2022) Clinical practice in the prevention, diagnosis and treatment of vitamin D deficiency: a Central and Eastern European Expert Consensus Statement. Nutrients 14, 1483.CrossRefGoogle ScholarPubMed
Gilsanz, V, Chalfant, J, Mo, AO, et al. (2009) Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab 94, 3387–3393.CrossRefGoogle ScholarPubMed
Kuchuk, NO, van Schoor, NM, Pluijm, SM, et al. (2009) Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 24, 693–701.CrossRefGoogle ScholarPubMed
Holick, MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80, 1678S–1688S.CrossRefGoogle ScholarPubMed
Ghasemifard, N, Hassanzadeh-Rostami, Z, Abbasi, A, et al. (2022) Effects of vitamin D-fortified oil intake v. vitamin D supplementation on vitamin D status and bone turnover factors: a double blind randomized clinical trial. Clin Nutr ESPEN 47, 28–35.CrossRefGoogle Scholar
Lee, Y-B, Baek, K-H, Chung, HY, et al. (2022) Raloxifene/vitamin D combination therapy v. raloxifene monotherapy on serum 25-hydroxy-vitamin D level among postmenopausal women with osteoporosis or osteopenia: a randomized controlled trial. J Bone Metab 29, 155–163.CrossRefGoogle ScholarPubMed
Välimäki, VV, Löyttyniemi, E, Pekkarinen, T, et al. (2016) How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? A placebo-controlled study on comparison between 100 000 μg and 200 000 μg of oral D3 every 3 months in elderly women. Clin Endocrinol 84, 837–844.CrossRefGoogle Scholar
Toxqui, L, Pérez-Granados, AM, Blanco-Rojo, R, et al. (2014) Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young Spanish women. Eur J Nutr 53, 441–448.CrossRefGoogle Scholar
Tangestani, H, Djafarian, K, Emamat, H, et al. (2020) Efficacy of vitamin D fortified foods on bone mineral density and serum bone biomarkers: a systematic review and meta-analysis of interventional studies. Crit Rev Food Sci Nutr 60, 1094–1103.CrossRefGoogle Scholar
Emadzadeh, M, Mehdizadeh, A, Sharifan, P, et al. (2022) The effects of vitamin D fortified products on bone biomarkers: a systematic review and meta-analysis. Iranian J Public Health 51, 278.Google Scholar
Cumpston, M, Li, T, Page, MJ, et al. (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane database of systematic reviews.Google Scholar
Moher, D, Liberati, A, Tetzlaff, J, et al. (2009) Preferred report items for systematic reviews meta-analyses: the PRISMA statement. PLoS Med 6, e1000097–1000096.CrossRefGoogle ScholarPubMed
Sterne, JA, Savović, J, Page, MJ, et al. (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898.CrossRefGoogle ScholarPubMed
Collaboration C (2011) 9.5. 2 Identifying and Measuring Heterogeneity, Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane database of systematic reviews. https://handbook-5-1.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm (accessed June 2023).Google Scholar
Raymond, JL & Morrow, K (2022) Krause and Mahan’s Food and the Nutrition Care Process, E-Book, 16th ed. Elsevier Health Sciences.Google Scholar
Egger, M, Smith, GD, Schneider, M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634.CrossRefGoogle ScholarPubMed
Cho, I-J, Chung, H-Y, Kim, S-W, et al. (2015) Efficacy of a once-monthly pill containing ibandronate and cholecalciferol on the levels of 25-hydroxyvitamin D and bone markers in postmenopausal women with osteoporosis. Endocrinol Metab 30, 272–279.CrossRefGoogle ScholarPubMed
Chung, HY, Koo, J, Kwon, SK, et al. (2013) Early changes in 25-hydroxyvitamin D levels and bone markers after monthly risedronate with cholecalciferol in Korean patients with osteoporosis. Clin Interv Aging 8, 597–603.CrossRefGoogle ScholarPubMed
Son, SM & Chun, YN (2001) Effect of oral therapy with alphacalcidol or calcium in Korean elderly women with osteopenia and low dietary calcium. Nutr Res 21, 1347–1355.CrossRefGoogle Scholar
Rodziewicz-Flis, EA, Kawa, M, Flis, DJ, et al. (2022) 12 weeks of physical exercise attenuates oxidative stress, improves functional tests performance, and reduces fall risk in elderly women independently on serum 25(OH)D concentration. Front Physiol 13, 809363.CrossRefGoogle ScholarPubMed
Zhang, Y & Wang, Y (2020) Clinical research of the application of bone turnover markers in monitoring the short-term therapeutic efficacy of vitamin D in postmenopausal osteoporotic women in harbin, China. J Nutr Health Ageing 24, 485–493.CrossRefGoogle ScholarPubMed
Cheng, Q, Wu, X, Du, Y, et al. (2018) Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol. Clin Interv Ageing 13, 2367–2374.CrossRefGoogle ScholarPubMed
Gao, L-H, Zhu, W-J, Liu, Y-J, et al. (2015) Physical performance and life quality in postmenopausal women supplemented with vitamin D: a two-year prospective study. Acta Pharmacol Sin 36, 1065–1073.CrossRefGoogle ScholarPubMed
Grønborg, IM, Tetens, I, Andersen, EW, et al. (2019) Effect of vitamin D fortified foods on bone markers and muscle strength in women of Pakistani and Danish origin living in Denmark: a randomised controlled trial. Nutr J 18, 1–12.CrossRefGoogle Scholar
Bislev, LS, Langagergaard Rødbro, L, Rolighed, L, et al. (2019) Bone microstructure in response to vitamin D3 supplementation: a randomized placebo-controlled trial. Calcified Tissue Int 104, 160–170.CrossRefGoogle ScholarPubMed
Uenishi, K, Tokiwa, M, Kato, S, et al. (2018) Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis. Osteoporosis Int 29, 723–732.CrossRefGoogle ScholarPubMed
Gorai, I, Hattori, S, Tanaka, Y, et al. (2012) Alfacalcidol-supplemented raloxifene therapy has greater bone-sparing effect than raloxifene-alone therapy in postmenopausal Japanese women with osteoporosis or osteopenia. J Bone Miner Metab 30, 349–358.CrossRefGoogle ScholarPubMed
Majima, T, Komatsu, Y, Shimatsu, A, et al. (2008) Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosis. Endocr J 55, 127–134.CrossRefGoogle Scholar
Shiraki, M, Fukuchi, M, Kiriyama, T, et al. (2004) Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis. J Bone Miner Metab 22, 352–359.CrossRefGoogle ScholarPubMed
Ushiroyama, T, Ikeda, A & Ueki, M (2002) Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas 41, 211–221.CrossRefGoogle Scholar
Ushiroyama, T, Ikeda, A, Sakai, M, et al. (2001) Effects of the combined use of calcitonin and 1α-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis:: a prospective study of long-term and continuous administration with low dose calcitonin. Maturitas 40, 229–238.CrossRefGoogle Scholar
Gorai, I, Chaki, O, Taguchi, Y, et al. (1999) Early postmenopausal bone loss is prevented by estrogen and partially by 1α-OH-vitamin D 3: therapeutic effects of estrogen and/or 1α-OH-vitamin D 3. Calcified Tissue Int 65, 16–22.CrossRefGoogle Scholar
Shiraki, M, Kushida, K, Yamazaki, K, et al. (1996) Effects of 2 years’ treatment of osteoporosis with 1α-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43, 211–220.CrossRefGoogle Scholar
Ushiroyama, T, Okamura, S, Ikeda, A, et al. (1995) Efficacy of ipriflavone and 1α vitamin D therapy for the cessation of vertebral bone loss. Int J Gynecol Obstet 48, 283–288.CrossRefGoogle Scholar
Nahas-Neto, J, Cangussu, L, Orsatti, C, et al. (2018) Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial. Osteoporosis Int 29, 1125–1133.CrossRefGoogle Scholar
Olmos, JM, Hernandez, JL, Llorca, J, et al. (2012) Effects of 25-hydroxyvitamin D3 therapy on bone turnover markers and PTH levels in postmenopausal osteoporotic women treated with alendronate. J Clin Endocrinol Metab 97, 4491–4497.CrossRefGoogle Scholar
Macdonald, HM, Wood, AD, Aucott, LS, et al. (2013) Hip bone loss is attenuated with 1000 μg but not 400 μg daily vitamin D3: a 1-year double-blind RCT in postmenopausal women. J Bone Miner Res 28, 2202–2213.CrossRefGoogle Scholar
Hunter, D, Major, P, Arden, N, et al. (2000) A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Miner Res 15, 2276–2283.CrossRefGoogle ScholarPubMed
Aloia, JF, Dhaliwal, R, Shieh, A, et al. (2013) Calcium and vitamin D supplementation in postmenopausal women. J Clin Endocrinol Metab 98, E1702–E1709.CrossRefGoogle ScholarPubMed
Von Hurst, P, Stonehouse, W, Kruger, M, et al. (2010) Vitamin D supplementation suppresses age-induced bone turnover in older women who are vitamin D deficient. J Steroid Biochem Mol Biol 121, 293–296.CrossRefGoogle ScholarPubMed
Manios, Y, Moschonis, G, Panagiotakos, D, et al. (2009) Changes in biochemical indices of bone metabolism in post-menopausal women following a dietary intervention with fortified dairy products. J Hum Nutr Diet 22, 156–165.CrossRefGoogle ScholarPubMed
Zhu, K, Bruce, D, Austin, N, et al. (2008) Randomized controlled trial of the effects of calcium with or without vitamin D on bone structure and bone-related chemistry in elderly women with vitamin D insufficiency. J Bone Miner Res 23, 1343–1348.CrossRefGoogle ScholarPubMed
Cooper, L, Clifton-Bligh, PB, Nery, ML, et al. (2003) Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 77, 1324–1329.CrossRefGoogle ScholarPubMed
Pfeifer, M, Begerow, B, Minne, HW, et al. (2000) Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15, 1113–1118.CrossRefGoogle ScholarPubMed
Ooms, ME, Roos, JC, Bezemer, PD, et al. (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80, 1052–1058.Google ScholarPubMed
Yamamoto, M, Kawanobe, Y, Takahashi, H, et al. (1984) Vitamin D deficiency and renal calcium transport in the rat. J Clin Investig 74, 507–513.CrossRefGoogle ScholarPubMed
Baldock, PA, Thomas, GP, Hodge, JM, et al. (2006) Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 21, 1618–1626.CrossRefGoogle ScholarPubMed
Ardawi, M-SM, Qari, M, Rouzi, A, et al. (2011) Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre-and postmenopausal women. Osteoporosis Int 22, 463–475.CrossRefGoogle ScholarPubMed
van Schoor, N, de Jongh, R & Lips, P (2024) Worldwide vitamin D status. Feldman Pike’s Vitamin D (Fifth Edition) 2, 47–75.CrossRefGoogle Scholar
Amrein, K, Scherkl, M, Hoffmann, M, et al. (2020) Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 74, 1498–1513.CrossRefGoogle ScholarPubMed
Kuang, X, Liu, C, Guo, X, et al. (2020) The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials. Food Funct 11, 3280–3297.CrossRefGoogle ScholarPubMed
Saadi, HF, Nagelkerke, N, Benedict, S, et al. (2006) Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone 39, 1136–1143.CrossRefGoogle ScholarPubMed
Aguayo-Ruiz, JI, García-Cobián, TA, Pascoe-González, S, et al. (2020) Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial. Diabetology Metab Syndrome 12, 1–10.CrossRefGoogle ScholarPubMed
Boucher-Berry, C, Speiser, PW, Carey, DE, et al. (2012) Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children. J Bone Miner Res 27, 283–293.CrossRefGoogle ScholarPubMed
Madar, AA, Knutsen, KV, Stene, LC, et al. (2015) Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): a randomized, double blinded, placebo controlled trial among healthy immigrants living in Norway. Bone Rep 2, 82–88.CrossRefGoogle Scholar
Wierzbicka, A & Oczkowicz, M (2022) Sex differences in vitamin D metabolism, serum levels and action. Br J Nutr 128, 2115–2130.CrossRefGoogle ScholarPubMed
Nasimi et al. supplementary material 1
Nasimi et al. supplementary material
File
785.4 KB
Nasimi et al. supplementary material 2
Nasimi et al. supplementary material
File
3.5 MB